Close Menu

consumer genomics

As many as 10,000 Nevadans will get free genetic testing through a large population health study being conducted by non-profit care network Renown Health. 

Early backers can get their genome or exome sequenced at discounted rates of $999 and $399, respectively, limited to the first 10 and 50 users in each case.

The company has developed a panel of 15 genes, identified from scientific literature, that specifically link to an athlete's potential to respond to power or endurance training.  

Only 5 percent of respondents said they got tested through a consumer genomics firm, but the future market could be worth as much as $7 billion, analysts at UBS estimated.

Portable's mobile app allows patients to capture genotype, phenotype, and other data, and potentially profit from sharing it with interested third parties.

The price of WGS is at that "magic number" everyone has been waiting for, but is it enough to take genomics mainstream?

Researchers from Brigham and Women's and Harvard surveyed more than 1,600 new customers of 23andMe or Pathway Genomics in the US, of whom 80 were adopted.

The partnerships are in the areas of consumer applications in reproductive health, and genetics-focused educational programs and entrepreneurship support.

The organization's bioethics committee called for a moratorium on germline editing and regulations on personal genomic testing.

The availability of consumer genomics services has also made it possible for adoptees to bypass state adoption laws, many of which restrict access to their records.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.